Digitalis Ventures is a venture capital firm that invests in solutions to complex problems in human and animal health. The firm provides capital to early-stage companies across life sciences, biotechnology, and healthcare technology.
36% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $58.8M (across 70 rounds with reported amounts).
Portfolio
54
Fund Size
$300M
Top Stage
Series A
Last 12 Mo
6
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
78 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| AAlpha-9 | Series C | $175M | Sep 2026 |
 Positive Development | Unknown | $45M | Jan 2026 |
 Aviceda | Series C | — | Jan 2026 |
 Eden Brew | Series A | $24.5M | Jan 2026 |
| AAviceda Therapeutics | Unknown | $207.5M | Jan 2026 |
 Protego Bio | Series B | $130M | Dec 2025 |
 Protego | Series B | $130M | Dec 2025 |
| PProtego Biopharma | Series B | $130M | Dec 2025 |
 Faeth Therapeutics | Unknown | $25M | Oct 2025 |
 Astra Therapeutics | Seed | — | Jul 2025 |
 Gallant | Series B | $18M | Jul 2025 |
| AAviceda Therapeutics | Series C | — | Jan 2025 |
| PProtego Biopharma | Series B | $130M | Jan 2025 |
 Nuvig Therapeutics | Series B | $161M | Dec 2024 |
| AAlpha-9 Oncology, Inc. | Series C | $175M | Oct 2024 |
| AAlpha-9 | Series C | $175M | Oct 2024 |
 Clasp | Unknown | $20M | Sep 2024 |
 Cardurion Pharmaceuticals | Series B | $260M | Jul 2024 |
 Expressable | Series B | $26M | May 2024 |
 Elegen | Series B | $35M | May 2024 |
 Alterome Therapeutics | Series B | $35M | Apr 2024 |
| AAlterome | Series B | $132M | Apr 2024 |
 MoeGo | Series A | $24M | Mar 2024 |
| Alterome Therapeutics | Series B | $132M | Jan 2024 |
 Ansel | Series A | $15M | Jan 2024 |
Page 1 of 4
Top Co-Investors
Two Sigma Ventures13 shared
Alexandria Venture Investments10 shared
Omega Funds9 shared
Lightspeed Venture Partners8 shared
Longitude Capital6 shared
OrbiMed6 shared
Brewer Lane Ventures6 shared
Operator Partners6 shared
Nextech Invest Ltd.6 shared
Madrona Venture Group5 shared
YK Bioventures5 shared
B Capital5 shared
Delos Capital5 shared
Sanofi Ventures5 shared
Founder Collective5 shared
S2G Ventures4 shared
Cantos4 shared
Future Fund4 shared
Koch Disruptive Technologies4 shared
Last updated: 20 October 2026